Division of Interventional Radiology, Department of Radiology, VCU Medical Center, Virginia Commonwealth University, Main Hospital. 1250 E. Marshall St. Room 3-407B1, Richmond, VA, 23219, USA.
Dig Dis Sci. 2019 Apr;64(4):951-958. doi: 10.1007/s10620-019-05514-9.
The most common primary liver malignancy, hepatocellular carcinoma (HCC), has a high likelihood of mortality, and much effort into early detection and treatment has occurred. Multiple staging systems have surfaced of which some guide treatment. Curative intent is a goal of early-staged HCC treatment, and this can be achieved with surgical resection, liver transplantation, and minimally invasive percutaneous therapies such as tumor ablation. Many of the newer ablation techniques have evolved from shortcomings of prior methods which have resulted in an expanded number of applications for tumor ablation. Our review focuses on current mainstream image-guided percutaneous ablation modalities which are commonly performed as an alternative to surgery.
最常见的原发性肝脏恶性肿瘤是肝细胞癌（HCC），其死亡率较高，因此人们进行了大量的早期检测和治疗工作。已经出现了多种分期系统，其中一些指导治疗。早期 HCC 治疗的目标是有治愈意图，可以通过手术切除、肝移植和微创经皮治疗（如肿瘤消融）来实现。许多新的消融技术都是从先前方法的缺点发展而来的，这导致了肿瘤消融的应用范围扩大。我们的综述重点介绍了目前常用的主流影像引导经皮消融方式，这些方式通常可作为手术的替代方法。
